Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Barlerin (8-O-Acetylshanzhiside methyl ester) 是一种环孢菌素葡萄糖苷,从中国西藏民间药用植物中分离得到,能够抑制NF-κB 活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 293 | 现货 | ||
2 mg | ¥ 425 | 现货 | ||
5 mg | ¥ 659 | 现货 | ||
10 mg | ¥ 956 | 现货 | ||
25 mg | ¥ 2,160 | 现货 | ||
50 mg | ¥ 2,790 | 现货 | ||
100 mg | ¥ 4,150 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 728 | 现货 |
产品描述 | Barlerin (8-O-Acetylshanzhiside methyl ester) has potential against cerebral ischemic injury, and its protective effect on oxygen-glucose deprivation-induced injury might be due to the suppression of intracellular Ca2+ elevation and caspase-3 activity, and improvement of mitochondrial energy metabolism.8-O-Acetylshanzhiside methylester can increase angiogenesis and improve functional recovery after stroke.8-O-Acetylshanzhiside methylester has protective effects on experimental myocardial ischemia injury, the effects might be due to block of myocardial inflammatory cascades through an HMGB1-dependent NF-κB signaling pathway.8-O-Acetylshanzhiside methylester protects diabetic brain against I/R injury by alleviating diabetic cerebral I/R injury and attenuating blood–brain barrier (BBB) breakdown, and its protective effects may involve HMGB-1 and NF-κB signalling pathway. |
别名 | 8-O-乙酰山栀苷甲酯, 8-O-Acetylshanzhiside methyl ester, ND01 |
分子量 | 448.42 |
分子式 | C19H28O12 |
CAS No. | 57420-46-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 82 mg/mL(182.9 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2301 mL | 11.1503 mL | 22.3005 mL | 55.7513 mL |
5 mM | 0.446 mL | 2.2301 mL | 4.4601 mL | 11.1503 mL | |
10 mM | 0.223 mL | 1.115 mL | 2.2301 mL | 5.5751 mL | |
20 mM | 0.1115 mL | 0.5575 mL | 1.115 mL | 2.7876 mL | |
50 mM | 0.0446 mL | 0.223 mL | 0.446 mL | 1.115 mL | |
100 mM | 0.0223 mL | 0.1115 mL | 0.223 mL | 0.5575 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Barlerin 57420-46-9 Angiogenesis Apoptosis Cytoskeletal Signaling NF-Κb PI3K/Akt/mTOR signaling Proteases/Proteasome Tyrosine Kinase/Adaptors VEGFR TNF NF-κB Akt Caspase inhibit Inhibitor 8-O-乙酰山栀苷甲酯 ND-01 8-O-Acetylshanzhiside methyl ester Nuclear factor-κB ND 01 Nuclear factor-kappaB ND01 inhibitor